BLUE

bluebird bio
BLUE

Overview Fund Activity
Delisted

BLUE was delisted on the 30th of May, 2025.

Back to rankings

148 hedge funds and large institutions have $78.3M invested in bluebird bio in 2024 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 37 increasing their positions, 47 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
148
Holders Change
-8
Holders Change %
-5.13%
% of All Funds
2.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
23
Increased
37
Reduced
47
Closed
30
Calls
$758K
Puts
$1.25M
Net Calls
-$495K
Net Calls Change
+$517K

Top Buyers

1
AQR Capital Management
1
AQR Capital Management
Connecticut
$1.22M
2
Deutsche Bank
2
Deutsche Bank
Germany
$1.15M
3
State Street
3
State Street
Massachusetts
$3.74M
4
SXL
4
Summit X LLC
Missouri
$577K
5
Jacobs Levy Equity Management
5
Jacobs Levy Equity Management
New Jersey
$327K

Top Sellers

1
GIM
1
Granahan Investment Management
Massachusetts
$0
2
TCM
2
Tang Capital Management
California
$0
3
PHS
3
PFM Health Sciences
California
$0
4
FLSM
4
Frazier Life Sciences Management
California
$0
5
Two Sigma Investments
5
Two Sigma Investments
New York
$894K
Name Holding Trade Value Shares
Change 		Shares
Change %
BC
176
Barrett & Company
Rhode Island
– -$256 -10 Closed
TC
177
Truvestments Capital
Florida
– -$160 -6 Closed
AWM
178
Avior Wealth Management
Nebraska
– -$29 -1 Closed
Zurich Cantonal Bank
179
Zurich Cantonal Bank
Switzerland
– -$4 – –
4 5 6 7
8